文献速递神经骨肌MR

脊髓型颈椎病:脊髓各向异性分数与初级运动皮层磁共振波谱变化及其与临床症状和病程的关系

Cervical spondylotic myelopathy: Changes of fractional anisotropy in the spinal cord and magnetic resonance spectroscopy of the primary motor cortex in relation to clinical symptoms and their duration.
PubMed 文献 · Eur J Radiol · 2019-04-16

前瞻性纳入20例脊髓型颈椎病患者与18名年龄性别匹配健康对照,行3T MR脊髓DTI(C2/3水平)FA及双侧中央前回MRS,分析其与mJOA、NDI及症状持续时间的相关性;患者FA及Cr、NAA浓度显著低于对照,症状≤6个月者Ins及Ins/Cr比值高于>6个月者。

要点

  • CSM患者C2/3水平脊髓FA显著低于健康对照(0.645±0.067 vs 0.699±0.037,p=0.005)。
  • 患者中央前回Cr与NAA浓度显著低于对照,提示代谢物改变。
  • 症状≤6个月者中央前回Ins及Ins/Cr比值高于症状>6个月者。

核心结论

  • 中央前回代谢谱与最上段脊髓FA在CSM患者与健康对照间存在显著差异;Ins在CSM早期病程中升高并随时间趋于正常化。

研究设计与样本

  • 前瞻性研究,纳入20例CSM患者(7例女性,平均年龄64.6±10.5岁)与18名年龄性别匹配健康对照(9例女性,平均年龄63.5±6.6岁),行3T MR脊髓DTI(C2/3水平)FA及左右中央前回MRS,并进行临床相关性与回归分析。

关键影像表现/征象

  • 脊髓C2/3水平FA在CSM患者为0.645±0.067,健康对照为0.699±0.037,患者显著降低(p=0.005)。
  • 中央前回Cr浓度CSM患者为46.46±7.64,健康对照为51.36±5.76,患者显著降低(p=0.03)。
  • 中央前回NAA浓度CSM患者为93.94±19.22,健康对照为107.24±20.20,患者显著降低(p=0.05)。
  • 症状持续时间≤6个月者中央前回Ins为61.58±17.76,>6个月者为44.44±10.79,≤6个月者显著升高(p=0.02)。
  • 症状持续时间≤6个月者Ins/Cr比值为1.36±0.47,>6个月者为0.96±0.18,≤6个月者显著升高(p=0.014)。

诊断标准与关键数值

  • CSM患者mJOA评分为10.2±2.9,健康对照为18.0±0.0,差异显著(p<0.001)。
  • CSM患者NDI为41.4±23.5,健康对照为4.4±6.6,差异显著(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine the changes in fractional anisotropy (FA) at the proximal spinal cord and in magnetic resonance spectroscopy (MRS) of the precentral gyrus in patients with cervical spondylotic myelopathy (CSM) with respect to clinical symptoms and their duration.

MATERIAL AND METHODS: 20 patients with CSM (7 female; mean age 64.6 ± 10.5 years) and 18 age/sex matched healthy controls (9 female; mean age 63.5 ± 6.6 years) were prospectively included. Clinical data (modified Japanese Orthopaedic Association Score (mJOA) and Neck Disability Index (NDI)) and 3T MR measurements including DTI at the spinal cord (level C2/3) with FA and MRS of the left and right precentral gyrus were taken. Clinical correlations and regression analyses were performed.

RESULTS: Mean clinical scores of patients were significantly different to controls (mJOA; CSM: 10.2 ± 2.9; controls: 18.0 ± 0.0, p < 0.001; NDI; CSM: 41.4±23.5; controls: 4.4±6.6, p<0.001); FA was significantly lower in patients (CSM: 0.645 ± 0.067; controls: 0.699 ± 0.037, p = 0.005). MRS showed significantly lower metabolite concentrations between both groups: creatine (Cr) (CSM: 46.46±7.64; controls: 51.36±5.76, p = 0.03) and N-acetylaspartate (NAA) (CSM: 93.94±19.22; controls: 107.24±20.20, p = 0.05). Duration of symptoms ≤6 months was associated with increased myo-inositol (Ins) (61.58±17.76; 44.44±10.79; p = 0.02) and Ins/Cr ratio (1.36±0.47; 0.96±0.18; p = 0.014) compared to symptoms >6 months.

CONCLUSION: Metabolic profiles of the precentral gyrus and FA in the uppermost spinal cord differ significantly between patients and healthy controls. Ins, thought to be a marker of endogenous neuroinflammatory response, is high in the early course of CSM and normalizes over time.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Gohmann RF, Blume C, Zvyagintsev M, et al. Cervical spondylotic myelopathy: Changes of fractional anisotropy in the spinal cord and magnetic resonance spectroscopy of the primary motor cortex in relation to clinical symptoms and their duration. Eur J Radiol. 2019. PMID: 31153574. doi:10.1016/j.ejrad.2019.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。